Enhancement of myeloperoxidase activity in wbcs in oral cancer patients treated with granulocyte macrophage colony stimulating factor (GM-CSF) - A pilot study
Publication Type:Journal Article
Source:Indian Journal of Clinical Biochemistry, Volume 13, Number 2, p.126-128 (1998)
In a pilot study with five oral cancer patients undergoing radiotherapy (RT) three were given Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) as a protective agent to reduce the mucosal inflammation during radiotherapy. The myeloperoxidase (MPO) enzyme activity in WBC was quantitated. The three patients snowed a significant increase in the MPO activity when compared with two untreated controls indicating the efficacy of GM-CSF as a protective agent. It is suggested that further detailed studies with larger number of patients would be useful.
cited By 0
Cite this Research Publication
Related Research Publications
- Positive influence of methotrexate-hydroxychloroquine combination on the expression of GM-CSF receptor on neutrophils of synovial fluid in rheumatoid arthritis
- Possible role of granulocyte macrophage colony stimulating factor receptor (GM-CSF R) in malaria
- Phagocytosis: A marker of decreased immune response in radiation treated oral cancers
- A multilectin affinity approach for comparative glycoprotein profiling of rheumatoid arthritis and spondyloarthropathy
- Synovial fluid proteome in rheumatoid arthritis.